nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE3B—brown adipose tissue—obesity	0.014	0.0669	CbGeAlD
Dipyridamole—ADA—brown adipose tissue—obesity	0.0106	0.0507	CbGeAlD
Dipyridamole—PDE6A—pituitary gland—obesity	0.0056	0.0268	CbGeAlD
Dipyridamole—PDE6B—respiratory system—obesity	0.00496	0.0237	CbGeAlD
Dipyridamole—PDE1C—cardiovascular system—obesity	0.00443	0.0212	CbGeAlD
Dipyridamole—PDE1A—hindbrain—obesity	0.00408	0.0195	CbGeAlD
Dipyridamole—PRUNE—pituitary gland—obesity	0.00354	0.0169	CbGeAlD
Dipyridamole—PRUNE—adipose tissue—obesity	0.00353	0.0169	CbGeAlD
Dipyridamole—PDE1C—adrenal gland—obesity	0.00351	0.0168	CbGeAlD
Dipyridamole—PDE6D—adipose tissue—obesity	0.00341	0.0163	CbGeAlD
Dipyridamole—PRUNE—adrenal gland—obesity	0.00316	0.0151	CbGeAlD
Dipyridamole—PDE6D—adrenal gland—obesity	0.00306	0.0146	CbGeAlD
Dipyridamole—PDE8B—islet of Langerhans—obesity	0.00303	0.0145	CbGeAlD
Dipyridamole—PDE6B—adrenal gland—obesity	0.00301	0.0144	CbGeAlD
Dipyridamole—PDE10A—respiratory system—obesity	0.003	0.0143	CbGeAlD
Dipyridamole—PDE3B—islet of Langerhans—obesity	0.00296	0.0142	CbGeAlD
Dipyridamole—PDE11A—adrenal gland—obesity	0.00279	0.0134	CbGeAlD
Dipyridamole—PDE8A—islet of Langerhans—obesity	0.00273	0.013	CbGeAlD
Dipyridamole—PDE6G—adrenal gland—obesity	0.00269	0.0129	CbGeAlD
Dipyridamole—PDE2A—adrenal cortex—obesity	0.00252	0.012	CbGeAlD
Dipyridamole—PRUNE—liver—obesity	0.00247	0.0118	CbGeAlD
Dipyridamole—PDE7B—adipose tissue—obesity	0.00243	0.0116	CbGeAlD
Dipyridamole—PDE6H—endocrine gland—obesity	0.00242	0.0116	CbGeAlD
Dipyridamole—PDE11A—endocrine gland—obesity	0.00242	0.0116	CbGeAlD
Dipyridamole—PDE6D—liver—obesity	0.00239	0.0114	CbGeAlD
Dipyridamole—PDE2A—cardiovascular system—obesity	0.0023	0.011	CbGeAlD
Dipyridamole—PDE11A—liver—obesity	0.00218	0.0104	CbGeAlD
Dipyridamole—PDE7B—adrenal gland—obesity	0.00218	0.0104	CbGeAlD
Dipyridamole—PDE8A—adrenal cortex—obesity	0.00216	0.0103	CbGeAlD
Dipyridamole—PDE7A—endocrine gland—obesity	0.00216	0.0103	CbGeAlD
Dipyridamole—PDE3B—cardiovascular system—obesity	0.00214	0.0102	CbGeAlD
Dipyridamole—ADA—respiratory system—obesity	0.00212	0.0101	CbGeAlD
Dipyridamole—PDE6G—liver—obesity	0.0021	0.0101	CbGeAlD
Dipyridamole—PDE2A—pituitary gland—obesity	0.00203	0.00973	CbGeAlD
Dipyridamole—PDE2A—adipose tissue—obesity	0.00203	0.00969	CbGeAlD
Dipyridamole—PDE10A—adipose tissue—obesity	0.00203	0.00969	CbGeAlD
Dipyridamole—PDE1B—adipose tissue—obesity	0.00201	0.0096	CbGeAlD
Dipyridamole—PDE8B—adipose tissue—obesity	0.00193	0.00924	CbGeAlD
Dipyridamole—PDE1A—cardiovascular system—obesity	0.00191	0.00912	CbGeAlD
Dipyridamole—PDE10A—digestive system—obesity	0.00191	0.00912	CbGeAlD
Dipyridamole—PDE3B—pituitary gland—obesity	0.0019	0.00906	CbGeAlD
Dipyridamole—PDE3B—adipose tissue—obesity	0.00189	0.00903	CbGeAlD
Dipyridamole—PDE10A—adrenal gland—obesity	0.00182	0.00869	CbGeAlD
Dipyridamole—PDE2A—adrenal gland—obesity	0.00182	0.00869	CbGeAlD
Dipyridamole—PDE1B—adrenal gland—obesity	0.0018	0.00861	CbGeAlD
Dipyridamole—PDE5A—respiratory system—obesity	0.00175	0.00839	CbGeAlD
Dipyridamole—PDE8A—pituitary gland—obesity	0.00175	0.00835	CbGeAlD
Dipyridamole—PDE8A—adipose tissue—obesity	0.00174	0.00831	CbGeAlD
Dipyridamole—PDE8B—adrenal gland—obesity	0.00173	0.00829	CbGeAlD
Dipyridamole—PDE7B—liver—obesity	0.0017	0.00814	CbGeAlD
Dipyridamole—PDE3B—adrenal gland—obesity	0.00169	0.0081	CbGeAlD
Dipyridamole—PDE1A—adipose tissue—obesity	0.00168	0.00804	CbGeAlD
Dipyridamole—ADA—cardiovascular system—obesity	0.00162	0.00776	CbGeAlD
Dipyridamole—PDE2A—endocrine gland—obesity	0.00158	0.00753	CbGeAlD
Dipyridamole—PDE1B—endocrine gland—obesity	0.00156	0.00747	CbGeAlD
Dipyridamole—SLC29A1—islet of Langerhans—obesity	0.00156	0.00746	CbGeAlD
Dipyridamole—PDE8A—adrenal gland—obesity	0.00156	0.00746	CbGeAlD
Dipyridamole—PDE1A—adrenal gland—obesity	0.00151	0.00722	CbGeAlD
Dipyridamole—PDE8B—endocrine gland—obesity	0.0015	0.00719	CbGeAlD
Dipyridamole—SLC29A1—respiratory system—obesity	0.00147	0.00705	CbGeAlD
Dipyridamole—PDE3B—endocrine gland—obesity	0.00147	0.00702	CbGeAlD
Dipyridamole—ADA—adipose tissue—obesity	0.00143	0.00684	CbGeAlD
Dipyridamole—PDE2A—liver—obesity	0.00142	0.00679	CbGeAlD
Dipyridamole—PDE4A—adipose tissue—obesity	0.00139	0.00667	CbGeAlD
Dipyridamole—PDE8B—liver—obesity	0.00136	0.00648	CbGeAlD
Dipyridamole—ADA—digestive system—obesity	0.00135	0.00644	CbGeAlD
Dipyridamole—PDE5A—cardiovascular system—obesity	0.00134	0.00643	CbGeAlD
Dipyridamole—PDE3B—liver—obesity	0.00132	0.00633	CbGeAlD
Dipyridamole—PDE1A—endocrine gland—obesity	0.00131	0.00626	CbGeAlD
Dipyridamole—PDE3A—cardiovascular system—obesity	0.00131	0.00625	CbGeAlD
Dipyridamole—ADA—adrenal gland—obesity	0.00128	0.00614	CbGeAlD
Dipyridamole—PDE4A—adrenal gland—obesity	0.00125	0.00598	CbGeAlD
Dipyridamole—SLC29A1—adrenal cortex—obesity	0.00124	0.00591	CbGeAlD
Dipyridamole—PDE8A—liver—obesity	0.00122	0.00583	CbGeAlD
Dipyridamole—PDE5A—adipose tissue—obesity	0.00119	0.00567	CbGeAlD
Dipyridamole—PDE1A—liver—obesity	0.00118	0.00564	CbGeAlD
Dipyridamole—PDE3A—adipose tissue—obesity	0.00115	0.00551	CbGeAlD
Dipyridamole—SLC29A1—cardiovascular system—obesity	0.00113	0.0054	CbGeAlD
Dipyridamole—PDE5A—digestive system—obesity	0.00112	0.00534	CbGeAlD
Dipyridamole—ADA—endocrine gland—obesity	0.00111	0.00532	CbGeAlD
Dipyridamole—ABCC5—pituitary gland—obesity	0.00109	0.00521	CbGeAlD
Dipyridamole—ABCC5—adipose tissue—obesity	0.00108	0.00518	CbGeAlD
Dipyridamole—PDE5A—adrenal gland—obesity	0.00106	0.00508	CbGeAlD
Dipyridamole—PDE3A—adrenal gland—obesity	0.00103	0.00495	CbGeAlD
Dipyridamole—SLC29A1—pituitary gland—obesity	0.000999	0.00478	CbGeAlD
Dipyridamole—SLC29A1—adipose tissue—obesity	0.000995	0.00476	CbGeAlD
Dipyridamole—ABCC5—adrenal gland—obesity	0.000972	0.00465	CbGeAlD
Dipyridamole—SLC29A1—digestive system—obesity	0.000937	0.00448	CbGeAlD
Dipyridamole—PDE5A—endocrine gland—obesity	0.000922	0.00441	CbGeAlD
Dipyridamole—PDE3A—endocrine gland—obesity	0.000897	0.00429	CbGeAlD
Dipyridamole—SLC29A1—adrenal gland—obesity	0.000893	0.00427	CbGeAlD
Dipyridamole—PDE3A—liver—obesity	0.000809	0.00387	CbGeAlD
Dipyridamole—SLC29A1—endocrine gland—obesity	0.000774	0.0037	CbGeAlD
Dipyridamole—ABCC5—liver—obesity	0.00076	0.00364	CbGeAlD
Dipyridamole—ABCC4—adipose tissue—obesity	0.000751	0.00359	CbGeAlD
Dipyridamole—ABCC4—digestive system—obesity	0.000707	0.00338	CbGeAlD
Dipyridamole—SLC29A1—liver—obesity	0.000698	0.00334	CbGeAlD
Dipyridamole—ABCC4—adrenal gland—obesity	0.000674	0.00322	CbGeAlD
Dipyridamole—ABCC4—endocrine gland—obesity	0.000584	0.0028	CbGeAlD
Dipyridamole—ABCC4—liver—obesity	0.000527	0.00252	CbGeAlD
Dipyridamole—Headache—Diethylpropion—obesity	0.000521	0.00144	CcSEcCtD
Dipyridamole—Rhinitis—Bupropion—obesity	0.00052	0.00144	CcSEcCtD
Dipyridamole—Hepatitis—Bupropion—obesity	0.000519	0.00143	CcSEcCtD
Dipyridamole—Haemorrhage—Bupropion—obesity	0.000519	0.00143	CcSEcCtD
Dipyridamole—Back pain—Orlistat—obesity	0.000518	0.00143	CcSEcCtD
Dipyridamole—Hypoaesthesia—Bupropion—obesity	0.000516	0.00143	CcSEcCtD
Dipyridamole—Pharyngitis—Bupropion—obesity	0.000515	0.00142	CcSEcCtD
Dipyridamole—Muscle spasms—Orlistat—obesity	0.000514	0.00142	CcSEcCtD
Dipyridamole—Hot flush—Topiramate—obesity	0.00051	0.00141	CcSEcCtD
Dipyridamole—Flatulence—Sibutramine—obesity	0.00051	0.00141	CcSEcCtD
Dipyridamole—Increased appetite—Topiramate—obesity	0.000508	0.00141	CcSEcCtD
Dipyridamole—Tension—Sibutramine—obesity	0.000508	0.0014	CcSEcCtD
Dipyridamole—Dysgeusia—Sibutramine—obesity	0.000507	0.0014	CcSEcCtD
Dipyridamole—Menopausal symptoms—Topiramate—obesity	0.000506	0.0014	CcSEcCtD
Dipyridamole—Nervousness—Sibutramine—obesity	0.000503	0.00139	CcSEcCtD
Dipyridamole—Vomiting—Cimetidine—obesity	0.000503	0.00139	CcSEcCtD
Dipyridamole—Thirst—Topiramate—obesity	0.000502	0.00139	CcSEcCtD
Dipyridamole—Back pain—Sibutramine—obesity	0.000501	0.00138	CcSEcCtD
Dipyridamole—Rash—Cimetidine—obesity	0.000499	0.00138	CcSEcCtD
Dipyridamole—Dermatitis—Cimetidine—obesity	0.000498	0.00138	CcSEcCtD
Dipyridamole—Muscle spasms—Sibutramine—obesity	0.000498	0.00138	CcSEcCtD
Dipyridamole—Ill-defined disorder—Orlistat—obesity	0.000496	0.00137	CcSEcCtD
Dipyridamole—Headache—Cimetidine—obesity	0.000495	0.00137	CcSEcCtD
Dipyridamole—Nausea—Diethylpropion—obesity	0.000494	0.00136	CcSEcCtD
Dipyridamole—Angioedema—Orlistat—obesity	0.000489	0.00135	CcSEcCtD
Dipyridamole—Tremor—Sibutramine—obesity	0.000485	0.00134	CcSEcCtD
Dipyridamole—Tinnitus—Bupropion—obesity	0.000483	0.00134	CcSEcCtD
Dipyridamole—Malaise—Orlistat—obesity	0.000482	0.00133	CcSEcCtD
Dipyridamole—Cardiac disorder—Bupropion—obesity	0.000481	0.00133	CcSEcCtD
Dipyridamole—Flushing—Bupropion—obesity	0.000481	0.00133	CcSEcCtD
Dipyridamole—Vertigo—Orlistat—obesity	0.000481	0.00133	CcSEcCtD
Dipyridamole—Ill-defined disorder—Sibutramine—obesity	0.00048	0.00133	CcSEcCtD
Dipyridamole—Anaemia—Sibutramine—obesity	0.000479	0.00132	CcSEcCtD
Dipyridamole—Angioedema—Sibutramine—obesity	0.000473	0.00131	CcSEcCtD
Dipyridamole—Palpitations—Orlistat—obesity	0.000473	0.00131	CcSEcCtD
Dipyridamole—Angiopathy—Bupropion—obesity	0.00047	0.0013	CcSEcCtD
Dipyridamole—Migraine—Topiramate—obesity	0.00047	0.0013	CcSEcCtD
Dipyridamole—Nausea—Cimetidine—obesity	0.00047	0.0013	CcSEcCtD
Dipyridamole—Immune system disorder—Bupropion—obesity	0.000468	0.00129	CcSEcCtD
Dipyridamole—Mediastinal disorder—Bupropion—obesity	0.000467	0.00129	CcSEcCtD
Dipyridamole—Malaise—Sibutramine—obesity	0.000467	0.00129	CcSEcCtD
Dipyridamole—Cough—Orlistat—obesity	0.000467	0.00129	CcSEcCtD
Dipyridamole—Chills—Bupropion—obesity	0.000465	0.00129	CcSEcCtD
Dipyridamole—Vertigo—Sibutramine—obesity	0.000465	0.00129	CcSEcCtD
Dipyridamole—Syncope—Sibutramine—obesity	0.000464	0.00128	CcSEcCtD
Dipyridamole—Convulsion—Orlistat—obesity	0.000464	0.00128	CcSEcCtD
Dipyridamole—Arrhythmia—Bupropion—obesity	0.000463	0.00128	CcSEcCtD
Dipyridamole—Alopecia—Bupropion—obesity	0.000458	0.00127	CcSEcCtD
Dipyridamole—Palpitations—Sibutramine—obesity	0.000458	0.00126	CcSEcCtD
Dipyridamole—Chest pain—Orlistat—obesity	0.000455	0.00126	CcSEcCtD
Dipyridamole—Myalgia—Orlistat—obesity	0.000455	0.00126	CcSEcCtD
Dipyridamole—Loss of consciousness—Sibutramine—obesity	0.000455	0.00126	CcSEcCtD
Dipyridamole—Anxiety—Orlistat—obesity	0.000454	0.00125	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000452	0.00125	CcSEcCtD
Dipyridamole—Cough—Sibutramine—obesity	0.000452	0.00125	CcSEcCtD
Dipyridamole—Discomfort—Orlistat—obesity	0.00045	0.00124	CcSEcCtD
Dipyridamole—Convulsion—Sibutramine—obesity	0.000449	0.00124	CcSEcCtD
Dipyridamole—Hypertension—Sibutramine—obesity	0.000447	0.00124	CcSEcCtD
Dipyridamole—Dry mouth—Orlistat—obesity	0.000445	0.00123	CcSEcCtD
Dipyridamole—Flatulence—Bupropion—obesity	0.000445	0.00123	CcSEcCtD
Dipyridamole—Tension—Bupropion—obesity	0.000443	0.00122	CcSEcCtD
Dipyridamole—Dysgeusia—Bupropion—obesity	0.000442	0.00122	CcSEcCtD
Dipyridamole—Arthralgia—Sibutramine—obesity	0.000441	0.00122	CcSEcCtD
Dipyridamole—Chest pain—Sibutramine—obesity	0.000441	0.00122	CcSEcCtD
Dipyridamole—Myalgia—Sibutramine—obesity	0.000441	0.00122	CcSEcCtD
Dipyridamole—Anxiety—Sibutramine—obesity	0.000439	0.00121	CcSEcCtD
Dipyridamole—Nervousness—Bupropion—obesity	0.000438	0.00121	CcSEcCtD
Dipyridamole—Oedema—Orlistat—obesity	0.000437	0.00121	CcSEcCtD
Dipyridamole—Anaphylactic shock—Orlistat—obesity	0.000437	0.00121	CcSEcCtD
Dipyridamole—Back pain—Bupropion—obesity	0.000437	0.00121	CcSEcCtD
Dipyridamole—Abdominal pain upper—Topiramate—obesity	0.000436	0.00121	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Topiramate—obesity	0.000436	0.00121	CcSEcCtD
Dipyridamole—Discomfort—Sibutramine—obesity	0.000436	0.0012	CcSEcCtD
Dipyridamole—Muscle spasms—Bupropion—obesity	0.000434	0.0012	CcSEcCtD
Dipyridamole—Dry mouth—Sibutramine—obesity	0.000431	0.00119	CcSEcCtD
Dipyridamole—Nervous system disorder—Orlistat—obesity	0.000428	0.00118	CcSEcCtD
Dipyridamole—Skin disorder—Orlistat—obesity	0.000424	0.00117	CcSEcCtD
Dipyridamole—Tremor—Bupropion—obesity	0.000423	0.00117	CcSEcCtD
Dipyridamole—Oedema—Sibutramine—obesity	0.000423	0.00117	CcSEcCtD
Dipyridamole—Anaphylactic shock—Sibutramine—obesity	0.000423	0.00117	CcSEcCtD
Dipyridamole—Hyperhidrosis—Orlistat—obesity	0.000422	0.00117	CcSEcCtD
Dipyridamole—Ill-defined disorder—Bupropion—obesity	0.000419	0.00116	CcSEcCtD
Dipyridamole—Anaemia—Bupropion—obesity	0.000417	0.00115	CcSEcCtD
Dipyridamole—Shock—Sibutramine—obesity	0.000416	0.00115	CcSEcCtD
Dipyridamole—Thrombocytopenia—Sibutramine—obesity	0.000414	0.00114	CcSEcCtD
Dipyridamole—Dysphagia—Topiramate—obesity	0.000413	0.00114	CcSEcCtD
Dipyridamole—Angioedema—Bupropion—obesity	0.000412	0.00114	CcSEcCtD
Dipyridamole—Tachycardia—Sibutramine—obesity	0.000412	0.00114	CcSEcCtD
Dipyridamole—Skin disorder—Sibutramine—obesity	0.00041	0.00113	CcSEcCtD
Dipyridamole—ABCB1—islet of Langerhans—obesity	0.00041	0.00196	CbGeAlD
Dipyridamole—Hyperhidrosis—Sibutramine—obesity	0.000409	0.00113	CcSEcCtD
Dipyridamole—Malaise—Bupropion—obesity	0.000407	0.00113	CcSEcCtD
Dipyridamole—Vertigo—Bupropion—obesity	0.000406	0.00112	CcSEcCtD
Dipyridamole—Syncope—Bupropion—obesity	0.000405	0.00112	CcSEcCtD
Dipyridamole—Sweating increased—Topiramate—obesity	0.000402	0.00111	CcSEcCtD
Dipyridamole—Angina pectoris—Topiramate—obesity	0.000402	0.00111	CcSEcCtD
Dipyridamole—Palpitations—Bupropion—obesity	0.000399	0.0011	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Orlistat—obesity	0.000398	0.0011	CcSEcCtD
Dipyridamole—Loss of consciousness—Bupropion—obesity	0.000397	0.0011	CcSEcCtD
Dipyridamole—Abdominal discomfort—Topiramate—obesity	0.000396	0.00109	CcSEcCtD
Dipyridamole—Hypotension—Sibutramine—obesity	0.000395	0.00109	CcSEcCtD
Dipyridamole—Cough—Bupropion—obesity	0.000394	0.00109	CcSEcCtD
Dipyridamole—Paraesthesia—Orlistat—obesity	0.000392	0.00108	CcSEcCtD
Dipyridamole—Convulsion—Bupropion—obesity	0.000391	0.00108	CcSEcCtD
Dipyridamole—Hypertension—Bupropion—obesity	0.00039	0.00108	CcSEcCtD
Dipyridamole—ABCB1—respiratory system—obesity	0.000387	0.00185	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Sibutramine—obesity	0.000385	0.00106	CcSEcCtD
Dipyridamole—Dyspepsia—Orlistat—obesity	0.000384	0.00106	CcSEcCtD
Dipyridamole—Chest pain—Bupropion—obesity	0.000384	0.00106	CcSEcCtD
Dipyridamole—Arthralgia—Bupropion—obesity	0.000384	0.00106	CcSEcCtD
Dipyridamole—Myalgia—Bupropion—obesity	0.000384	0.00106	CcSEcCtD
Dipyridamole—Anxiety—Bupropion—obesity	0.000383	0.00106	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000382	0.00106	CcSEcCtD
Dipyridamole—Discomfort—Bupropion—obesity	0.00038	0.00105	CcSEcCtD
Dipyridamole—Paraesthesia—Sibutramine—obesity	0.000379	0.00105	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Orlistat—obesity	0.000377	0.00104	CcSEcCtD
Dipyridamole—Dyspnoea—Sibutramine—obesity	0.000377	0.00104	CcSEcCtD
Dipyridamole—Fatigue—Orlistat—obesity	0.000376	0.00104	CcSEcCtD
Dipyridamole—Dry mouth—Bupropion—obesity	0.000376	0.00104	CcSEcCtD
Dipyridamole—Somnolence—Sibutramine—obesity	0.000376	0.00104	CcSEcCtD
Dipyridamole—Pain—Orlistat—obesity	0.000373	0.00103	CcSEcCtD
Dipyridamole—Dyspepsia—Sibutramine—obesity	0.000372	0.00103	CcSEcCtD
Dipyridamole—Anaphylactic shock—Bupropion—obesity	0.000368	0.00102	CcSEcCtD
Dipyridamole—Oedema—Bupropion—obesity	0.000368	0.00102	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Sibutramine—obesity	0.000365	0.00101	CcSEcCtD
Dipyridamole—Shock—Bupropion—obesity	0.000362	0.001	CcSEcCtD
Dipyridamole—Pain—Sibutramine—obesity	0.000361	0.000999	CcSEcCtD
Dipyridamole—Nervous system disorder—Bupropion—obesity	0.000361	0.000999	CcSEcCtD
Dipyridamole—Thrombocytopenia—Bupropion—obesity	0.000361	0.000997	CcSEcCtD
Dipyridamole—Feeling abnormal—Orlistat—obesity	0.00036	0.000995	CcSEcCtD
Dipyridamole—Tachycardia—Bupropion—obesity	0.00036	0.000994	CcSEcCtD
Dipyridamole—Skin disorder—Bupropion—obesity	0.000358	0.000989	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Orlistat—obesity	0.000357	0.000987	CcSEcCtD
Dipyridamole—Hyperhidrosis—Bupropion—obesity	0.000356	0.000985	CcSEcCtD
Dipyridamole—Feeling abnormal—Sibutramine—obesity	0.000348	0.000963	CcSEcCtD
Dipyridamole—Urticaria—Orlistat—obesity	0.000347	0.000959	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Sibutramine—obesity	0.000346	0.000955	CcSEcCtD
Dipyridamole—Abdominal pain—Orlistat—obesity	0.000345	0.000954	CcSEcCtD
Dipyridamole—Hypotension—Bupropion—obesity	0.000344	0.000952	CcSEcCtD
Dipyridamole—Bradycardia—Topiramate—obesity	0.000336	0.00093	CcSEcCtD
Dipyridamole—Urticaria—Sibutramine—obesity	0.000336	0.000928	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Bupropion—obesity	0.000336	0.000928	CcSEcCtD
Dipyridamole—Abdominal pain—Sibutramine—obesity	0.000334	0.000923	CcSEcCtD
Dipyridamole—Haemoglobin—Topiramate—obesity	0.000332	0.000918	CcSEcCtD
Dipyridamole—Rhinitis—Topiramate—obesity	0.000331	0.000916	CcSEcCtD
Dipyridamole—Paraesthesia—Bupropion—obesity	0.000331	0.000915	CcSEcCtD
Dipyridamole—Hepatitis—Topiramate—obesity	0.00033	0.000913	CcSEcCtD
Dipyridamole—Haemorrhage—Topiramate—obesity	0.00033	0.000913	CcSEcCtD
Dipyridamole—Hypoaesthesia—Topiramate—obesity	0.000329	0.000909	CcSEcCtD
Dipyridamole—Dyspnoea—Bupropion—obesity	0.000328	0.000908	CcSEcCtD
Dipyridamole—Pharyngitis—Topiramate—obesity	0.000328	0.000906	CcSEcCtD
Dipyridamole—Somnolence—Bupropion—obesity	0.000328	0.000905	CcSEcCtD
Dipyridamole—ABCB1—adrenal cortex—obesity	0.000325	0.00155	CbGeAlD
Dipyridamole—Dyspepsia—Bupropion—obesity	0.000324	0.000896	CcSEcCtD
Dipyridamole—Hypersensitivity—Orlistat—obesity	0.000322	0.000889	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Bupropion—obesity	0.000318	0.000879	CcSEcCtD
Dipyridamole—Fatigue—Bupropion—obesity	0.000318	0.000878	CcSEcCtD
Dipyridamole—Pain—Bupropion—obesity	0.000315	0.000871	CcSEcCtD
Dipyridamole—Asthenia—Orlistat—obesity	0.000313	0.000866	CcSEcCtD
Dipyridamole—Hypersensitivity—Sibutramine—obesity	0.000311	0.000861	CcSEcCtD
Dipyridamole—Pruritus—Orlistat—obesity	0.000309	0.000854	CcSEcCtD
Dipyridamole—Tinnitus—Topiramate—obesity	0.000308	0.000852	CcSEcCtD
Dipyridamole—Cardiac disorder—Topiramate—obesity	0.000307	0.000848	CcSEcCtD
Dipyridamole—Flushing—Topiramate—obesity	0.000307	0.000848	CcSEcCtD
Dipyridamole—Feeling abnormal—Bupropion—obesity	0.000304	0.000839	CcSEcCtD
Dipyridamole—Asthenia—Sibutramine—obesity	0.000303	0.000838	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Bupropion—obesity	0.000301	0.000833	CcSEcCtD
Dipyridamole—Angiopathy—Topiramate—obesity	0.0003	0.000829	CcSEcCtD
Dipyridamole—Pruritus—Sibutramine—obesity	0.000299	0.000827	CcSEcCtD
Dipyridamole—Diarrhoea—Orlistat—obesity	0.000299	0.000826	CcSEcCtD
Dipyridamole—Immune system disorder—Topiramate—obesity	0.000298	0.000825	CcSEcCtD
Dipyridamole—Mediastinal disorder—Topiramate—obesity	0.000298	0.000823	CcSEcCtD
Dipyridamole—ABCB1—cardiovascular system—obesity	0.000297	0.00142	CbGeAlD
Dipyridamole—Chills—Topiramate—obesity	0.000296	0.000819	CcSEcCtD
Dipyridamole—Urticaria—Bupropion—obesity	0.000293	0.000809	CcSEcCtD
Dipyridamole—Alopecia—Topiramate—obesity	0.000292	0.000807	CcSEcCtD
Dipyridamole—Abdominal pain—Bupropion—obesity	0.000291	0.000805	CcSEcCtD
Dipyridamole—Diarrhoea—Sibutramine—obesity	0.000289	0.000799	CcSEcCtD
Dipyridamole—Dizziness—Orlistat—obesity	0.000289	0.000798	CcSEcCtD
Dipyridamole—Flatulence—Topiramate—obesity	0.000283	0.000783	CcSEcCtD
Dipyridamole—Tension—Topiramate—obesity	0.000282	0.00078	CcSEcCtD
Dipyridamole—Dysgeusia—Topiramate—obesity	0.000282	0.000779	CcSEcCtD
Dipyridamole—Dizziness—Sibutramine—obesity	0.000279	0.000773	CcSEcCtD
Dipyridamole—Nervousness—Topiramate—obesity	0.000279	0.000772	CcSEcCtD
Dipyridamole—Back pain—Topiramate—obesity	0.000278	0.000769	CcSEcCtD
Dipyridamole—Vomiting—Orlistat—obesity	0.000278	0.000767	CcSEcCtD
Dipyridamole—Muscle spasms—Topiramate—obesity	0.000276	0.000764	CcSEcCtD
Dipyridamole—Rash—Orlistat—obesity	0.000275	0.000761	CcSEcCtD
Dipyridamole—Dermatitis—Orlistat—obesity	0.000275	0.00076	CcSEcCtD
Dipyridamole—Headache—Orlistat—obesity	0.000274	0.000756	CcSEcCtD
Dipyridamole—Hypersensitivity—Bupropion—obesity	0.000271	0.00075	CcSEcCtD
Dipyridamole—Tremor—Topiramate—obesity	0.000269	0.000745	CcSEcCtD
Dipyridamole—Vomiting—Sibutramine—obesity	0.000269	0.000743	CcSEcCtD
Dipyridamole—Ill-defined disorder—Topiramate—obesity	0.000267	0.000738	CcSEcCtD
Dipyridamole—Rash—Sibutramine—obesity	0.000266	0.000737	CcSEcCtD
Dipyridamole—Dermatitis—Sibutramine—obesity	0.000266	0.000736	CcSEcCtD
Dipyridamole—Anaemia—Topiramate—obesity	0.000266	0.000735	CcSEcCtD
Dipyridamole—Headache—Sibutramine—obesity	0.000265	0.000732	CcSEcCtD
Dipyridamole—Asthenia—Bupropion—obesity	0.000264	0.000731	CcSEcCtD
Dipyridamole—ABCB1—pituitary gland—obesity	0.000263	0.00126	CbGeAlD
Dipyridamole—ABCB1—adipose tissue—obesity	0.000262	0.00125	CbGeAlD
Dipyridamole—Pruritus—Bupropion—obesity	0.000261	0.000721	CcSEcCtD
Dipyridamole—Nausea—Orlistat—obesity	0.000259	0.000717	CcSEcCtD
Dipyridamole—Malaise—Topiramate—obesity	0.000259	0.000717	CcSEcCtD
Dipyridamole—Vertigo—Topiramate—obesity	0.000258	0.000714	CcSEcCtD
Dipyridamole—Syncope—Topiramate—obesity	0.000258	0.000713	CcSEcCtD
Dipyridamole—Palpitations—Topiramate—obesity	0.000254	0.000703	CcSEcCtD
Dipyridamole—Loss of consciousness—Topiramate—obesity	0.000253	0.000699	CcSEcCtD
Dipyridamole—Diarrhoea—Bupropion—obesity	0.000252	0.000697	CcSEcCtD
Dipyridamole—Nausea—Sibutramine—obesity	0.000251	0.000694	CcSEcCtD
Dipyridamole—Cough—Topiramate—obesity	0.000251	0.000694	CcSEcCtD
Dipyridamole—Convulsion—Topiramate—obesity	0.000249	0.000689	CcSEcCtD
Dipyridamole—Hypertension—Topiramate—obesity	0.000248	0.000686	CcSEcCtD
Dipyridamole—ABCB1—digestive system—obesity	0.000246	0.00118	CbGeAlD
Dipyridamole—Arthralgia—Topiramate—obesity	0.000245	0.000677	CcSEcCtD
Dipyridamole—Myalgia—Topiramate—obesity	0.000245	0.000677	CcSEcCtD
Dipyridamole—Chest pain—Topiramate—obesity	0.000245	0.000677	CcSEcCtD
Dipyridamole—Anxiety—Topiramate—obesity	0.000244	0.000675	CcSEcCtD
Dipyridamole—Dizziness—Bupropion—obesity	0.000244	0.000673	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000243	0.000672	CcSEcCtD
Dipyridamole—Discomfort—Topiramate—obesity	0.000242	0.000669	CcSEcCtD
Dipyridamole—Dry mouth—Topiramate—obesity	0.000239	0.000662	CcSEcCtD
Dipyridamole—Oedema—Topiramate—obesity	0.000235	0.000649	CcSEcCtD
Dipyridamole—ABCB1—adrenal gland—obesity	0.000235	0.00112	CbGeAlD
Dipyridamole—Vomiting—Bupropion—obesity	0.000234	0.000648	CcSEcCtD
Dipyridamole—Rash—Bupropion—obesity	0.000232	0.000642	CcSEcCtD
Dipyridamole—Dermatitis—Bupropion—obesity	0.000232	0.000642	CcSEcCtD
Dipyridamole—Shock—Topiramate—obesity	0.000231	0.000638	CcSEcCtD
Dipyridamole—Headache—Bupropion—obesity	0.000231	0.000638	CcSEcCtD
Dipyridamole—Nervous system disorder—Topiramate—obesity	0.00023	0.000636	CcSEcCtD
Dipyridamole—Thrombocytopenia—Topiramate—obesity	0.00023	0.000635	CcSEcCtD
Dipyridamole—Tachycardia—Topiramate—obesity	0.000229	0.000633	CcSEcCtD
Dipyridamole—Skin disorder—Topiramate—obesity	0.000228	0.00063	CcSEcCtD
Dipyridamole—Hyperhidrosis—Topiramate—obesity	0.000227	0.000627	CcSEcCtD
Dipyridamole—Hypotension—Topiramate—obesity	0.000219	0.000606	CcSEcCtD
Dipyridamole—Nausea—Bupropion—obesity	0.000219	0.000605	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Topiramate—obesity	0.000214	0.000591	CcSEcCtD
Dipyridamole—Paraesthesia—Topiramate—obesity	0.000211	0.000583	CcSEcCtD
Dipyridamole—Dyspnoea—Topiramate—obesity	0.000209	0.000578	CcSEcCtD
Dipyridamole—Somnolence—Topiramate—obesity	0.000209	0.000577	CcSEcCtD
Dipyridamole—Dyspepsia—Topiramate—obesity	0.000207	0.000571	CcSEcCtD
Dipyridamole—ABCB1—endocrine gland—obesity	0.000203	0.000973	CbGeAlD
Dipyridamole—Gastrointestinal disorder—Topiramate—obesity	0.000203	0.00056	CcSEcCtD
Dipyridamole—Fatigue—Topiramate—obesity	0.000202	0.000559	CcSEcCtD
Dipyridamole—Pain—Topiramate—obesity	0.000201	0.000555	CcSEcCtD
Dipyridamole—Feeling abnormal—Topiramate—obesity	0.000193	0.000535	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Topiramate—obesity	0.000192	0.000531	CcSEcCtD
Dipyridamole—Urticaria—Topiramate—obesity	0.000186	0.000515	CcSEcCtD
Dipyridamole—Abdominal pain—Topiramate—obesity	0.000186	0.000513	CcSEcCtD
Dipyridamole—ABCB1—liver—obesity	0.000183	0.000877	CbGeAlD
Dipyridamole—Hypersensitivity—Topiramate—obesity	0.000173	0.000478	CcSEcCtD
Dipyridamole—Asthenia—Topiramate—obesity	0.000168	0.000466	CcSEcCtD
Dipyridamole—Pruritus—Topiramate—obesity	0.000166	0.000459	CcSEcCtD
Dipyridamole—Diarrhoea—Topiramate—obesity	0.000161	0.000444	CcSEcCtD
Dipyridamole—Dizziness—Topiramate—obesity	0.000155	0.000429	CcSEcCtD
Dipyridamole—Vomiting—Topiramate—obesity	0.000149	0.000413	CcSEcCtD
Dipyridamole—Rash—Topiramate—obesity	0.000148	0.000409	CcSEcCtD
Dipyridamole—Dermatitis—Topiramate—obesity	0.000148	0.000409	CcSEcCtD
Dipyridamole—Headache—Topiramate—obesity	0.000147	0.000406	CcSEcCtD
Dipyridamole—Nausea—Topiramate—obesity	0.000139	0.000385	CcSEcCtD
Dipyridamole—PDE3B—Signaling Pathways—TYK2—obesity	6.72e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—obesity	6.7e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RHOA—obesity	6.67e-06	1.55e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1—obesity	6.63e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT2—obesity	6.62e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	6.62e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOB—obesity	6.61e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	6.6e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOS3—obesity	6.6e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3R1—obesity	6.6e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ESR1—obesity	6.59e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ACP5—obesity	6.56e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CD—obesity	6.54e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—F2—obesity	6.5e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PRKCB—obesity	6.5e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PIK3CA—obesity	6.5e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PIK3CA—obesity	6.48e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—POMC—obesity	6.48e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SERPINE1—obesity	6.47e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—INS—obesity	6.44e-06	1.5e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PIK3CA—obesity	6.44e-06	1.5e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PIK3CA—obesity	6.44e-06	1.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BAD—obesity	6.43e-06	1.5e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—G6PD—obesity	6.39e-06	1.49e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CD—obesity	6.36e-06	1.48e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—obesity	6.35e-06	1.48e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—obesity	6.35e-06	1.48e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—obesity	6.34e-06	1.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SREBF2—obesity	6.32e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HK1—obesity	6.32e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—obesity	6.31e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PIK3CA—obesity	6.3e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SERPINE1—obesity	6.29e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TYK2—obesity	6.29e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PIK3CA—obesity	6.28e-06	1.46e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RHOA—obesity	6.24e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CB—obesity	6.24e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK8—obesity	6.24e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—obesity	6.23e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1—obesity	6.23e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT2—obesity	6.23e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CG—obesity	6.22e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—obesity	6.18e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—obesity	6.18e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—obesity	6.18e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3R1—obesity	6.18e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	6.17e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IRS1—obesity	6.15e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—obesity	6.13e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TYK2—obesity	6.12e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPA—obesity	6.1e-06	1.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MTOR—obesity	6.09e-06	1.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CB—obesity	6.09e-06	1.42e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RHOA—obesity	6.07e-06	1.41e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3R1—obesity	6.01e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—obesity	6.01e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CD—obesity	5.98e-06	1.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPIN1—obesity	5.97e-06	1.39e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PIK3CA—obesity	5.97e-06	1.39e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PIK3CA—obesity	5.93e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—POMC—obesity	5.93e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SERPINE1—obesity	5.92e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—INS—obesity	5.89e-06	1.37e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PIK3CA—obesity	5.89e-06	1.37e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PIK3CA—obesity	5.88e-06	1.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA5—obesity	5.85e-06	1.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—obesity	5.8e-06	1.35e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TYK2—obesity	5.76e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—obesity	5.76e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—obesity	5.76e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PIK3CA—obesity	5.74e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PIK3CA—obesity	5.72e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RHOA—obesity	5.71e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CB—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MTOR—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT2—obesity	5.7e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—obesity	5.66e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—obesity	5.65e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—obesity	5.65e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3R1—obesity	5.65e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	5.62e-06	1.31e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC22A1—obesity	5.58e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CLOCK—obesity	5.58e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	5.58e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—obesity	5.57e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CB—obesity	5.55e-06	1.29e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MTOR—obesity	5.55e-06	1.29e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CD—obesity	5.47e-06	1.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SULT2A1—obesity	5.44e-06	1.27e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GLP1R—obesity	5.44e-06	1.27e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—obesity	5.42e-06	1.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SERPINE1—obesity	5.41e-06	1.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—obesity	5.38e-06	1.25e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DPYD—obesity	5.35e-06	1.25e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—obesity	5.35e-06	1.25e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—obesity	5.35e-06	1.25e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—obesity	5.34e-06	1.24e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—obesity	5.34e-06	1.24e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—obesity	5.31e-06	1.24e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—obesity	5.29e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—obesity	5.29e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—obesity	5.28e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TYK2—obesity	5.26e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—obesity	5.26e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—obesity	5.26e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—obesity	5.26e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—obesity	5.23e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	5.23e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RHOA—obesity	5.22e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MTOR—obesity	5.22e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CB—obesity	5.22e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—obesity	5.21e-06	1.21e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—obesity	5.21e-06	1.21e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3R1—obesity	5.17e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—obesity	5.17e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—obesity	5.15e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PRKAR2B—obesity	5.15e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK8—obesity	5.15e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—obesity	5.13e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DCN—obesity	5.11e-06	1.19e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—obesity	5.08e-06	1.18e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—obesity	5.07e-06	1.18e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CPT1A—obesity	4.97e-06	1.16e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—obesity	4.96e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—obesity	4.92e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—obesity	4.92e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—obesity	4.89e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—obesity	4.88e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NAMPT—obesity	4.88e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—obesity	4.88e-06	1.14e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LIPC—obesity	4.85e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCK—obesity	4.85e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—obesity	4.84e-06	1.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—obesity	4.82e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK8—obesity	4.82e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOC3—obesity	4.82e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—obesity	4.81e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—obesity	4.81e-06	1.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MTOR—obesity	4.77e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CB—obesity	4.77e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—obesity	4.77e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—obesity	4.71e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK8—obesity	4.69e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—obesity	4.69e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—obesity	4.68e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CETP—obesity	4.68e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SDC1—obesity	4.62e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	4.59e-06	1.07e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKR1C3—obesity	4.55e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—obesity	4.54e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—obesity	4.54e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—obesity	4.53e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—obesity	4.5e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SCARB1—obesity	4.48e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—obesity	4.43e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK8—obesity	4.41e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—obesity	4.41e-06	1.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—obesity	4.4e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—obesity	4.37e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—obesity	4.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—obesity	4.36e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—obesity	4.35e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SREBF1—obesity	4.35e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—obesity	4.29e-06	9.99e-06	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—obesity	4.27e-06	9.96e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GOT2—obesity	4.23e-06	9.85e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—obesity	4.15e-06	9.68e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—obesity	4.15e-06	9.66e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—obesity	4.14e-06	9.66e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—FASN—obesity	4.14e-06	9.64e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BCHE—obesity	4.12e-06	9.6e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—obesity	4.09e-06	9.54e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—obesity	4.08e-06	9.52e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK8—obesity	4.03e-06	9.4e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—obesity	4.03e-06	9.39e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—obesity	4.02e-06	9.37e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—obesity	4.02e-06	9.37e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—obesity	4.02e-06	9.37e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—obesity	4.02e-06	9.36e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—obesity	3.98e-06	9.28e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—obesity	3.98e-06	9.28e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2E1—obesity	3.98e-06	9.26e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—obesity	3.97e-06	9.26e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NQO1—obesity	3.93e-06	9.16e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—obesity	3.8e-06	8.86e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A4—obesity	3.77e-06	8.78e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCG—obesity	3.77e-06	8.78e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—obesity	3.75e-06	8.73e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—obesity	3.74e-06	8.71e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYCS—obesity	3.72e-06	8.67e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—obesity	3.71e-06	8.65e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—obesity	3.71e-06	8.64e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—obesity	3.71e-06	8.64e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—obesity	3.69e-06	8.59e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—obesity	3.68e-06	8.57e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—obesity	3.67e-06	8.56e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GGT1—obesity	3.65e-06	8.5e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GOT1—obesity	3.65e-06	8.5e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOA1—obesity	3.59e-06	8.38e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—STK11—obesity	3.54e-06	8.26e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP19A1—obesity	3.54e-06	8.26e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—obesity	3.48e-06	8.1e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—obesity	3.43e-06	7.98e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—obesity	3.42e-06	7.96e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—obesity	3.39e-06	7.9e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—obesity	3.38e-06	7.88e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—COMT—obesity	3.29e-06	7.68e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—obesity	3.29e-06	7.66e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARGC1A—obesity	3.25e-06	7.57e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNB3—obesity	3.25e-06	7.57e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMOX1—obesity	3.23e-06	7.53e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—obesity	3.18e-06	7.41e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNAS—obesity	3.16e-06	7.37e-06	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—obesity	3.11e-06	7.24e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOB—obesity	3.1e-06	7.22e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—obesity	3.08e-06	7.17e-06	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—obesity	3.03e-06	7.07e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—obesity	2.99e-06	6.98e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPL—obesity	2.96e-06	6.89e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—obesity	2.91e-06	6.78e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPX1—obesity	2.88e-06	6.72e-06	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—obesity	2.84e-06	6.62e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—obesity	2.82e-06	6.56e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CD36—obesity	2.81e-06	6.55e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—obesity	2.76e-06	6.44e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—obesity	2.66e-06	6.2e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARA—obesity	2.61e-06	6.09e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—obesity	2.6e-06	6.05e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—obesity	2.57e-06	6e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AGT—obesity	2.53e-06	5.89e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—obesity	2.48e-06	5.78e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAV1—obesity	2.46e-06	5.72e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA1—obesity	2.45e-06	5.71e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—obesity	2.38e-06	5.53e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CG—obesity	2.24e-06	5.21e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—obesity	2.16e-06	5.03e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—obesity	2.13e-06	4.96e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—INS—obesity	2.12e-06	4.93e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CD—obesity	1.97e-06	4.58e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—obesity	1.94e-06	4.52e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3R1—obesity	1.86e-06	4.33e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—obesity	1.86e-06	4.33e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CB—obesity	1.71e-06	3.99e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—obesity	1.7e-06	3.96e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—obesity	1.04e-06	2.43e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—obesity	8.54e-07	1.99e-06	CbGpPWpGaD
